AIMC Topic: Thrombolytic Therapy

Clear Filters Showing 31 to 32 of 32 articles

Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon.

Journal of thrombosis and thrombolysis Nov 1, 2020
The pandemic of coronavirus disease 2019 (COVID-19) has become a public health emergency of international concern. During this time, the management of people with acute coronary syndromes (ACS) and COVID-19 has become a global issue, especially since...
Humans Pandemics COVID-19 Risk Factors Infection Control Occupational Exposure Treatment Outcome Robotics Thrombolytic Therapy ST Elevation Myocardial Infarction Percutaneous Coronary Intervention Coronavirus Infections Acute Coronary Syndrome Motor Activity Pneumonia, Viral Infectious Disease Transmission, Patient-to-Professional Personal Protective Equipment
View on PubMed DOI

[Signifiance of brush sign on susceptibility-weighted imaging predicts hemorrhagic transformation after intravenous thrombolysis in patients with acute ischemic stroke].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences Nov 1, 2015
OBJECTIVE: To assess brush sign (BS) on susceptibility-weighted imaging (SWI) in prediction of hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS) after intravenous thrombolysis(IVT).
Humans Female Aged Aged, 80 and over Male Middle Aged Recombinant Proteins United States Treatment Outcome Thrombolytic Therapy Diagnostic Imaging Stroke Brain Ischemia Tissue Plasminogen Activator Administration, Intravenous Carotid Artery, Internal
View on PubMed DOI
Popular Topics
Recent Journals